---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-022912"
form_type: "8-K"
ticker: "IMDX"
cik: "0001642380"
company_name: "Insight Molecular Diagnostics Inc."
filed_at: "2023-06-29T23:59:59+00:00"
generated_at: "2026-06-13T14:55:19.223438+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Oncocyte annual meeting results: directors elected, auditor ratified, say-on-pay approved

## Summary
- All five board nominees (Riggs, Arno, Kingsley, Last, Silverman) elected; each received >78.8M votes for.
- Ratification of WithumSmith+Brown as auditor approved: 126.4M for, 714K against, 659K abstain.
- Advisory vote on named executive officer compensation passed: 79.0M for, 5.3M against, 128K abstain.
- Turnout was 77.62% (127.8M shares present); broker non-votes 43.4M on director and compensation votes.

## SEC filing metadata
- accession: 0001493152-23-022912
- form_type: 8-K
- ticker: IMDX
- cik: 0001642380
- company_name: Insight Molecular Diagnostics Inc.
- filed_at: 2023-06-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642380/000149315223022912/0001493152-23-022912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642380/000149315223022912/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-022912
- JSON: https://secwatch.observer/filing/0001493152-23-022912.json
- Plain text: https://secwatch.observer/filing/0001493152-23-022912.txt

## Key facts
- Shareholder Votes
  Insight Molecular Diagnostics Inc. shareholders approved To elect five (5) directors to hold office until the next annual meeting of shareholders and until their respective successors are duly elected and qualified. at the 2023-06-23 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-23
  source text: 1. Election of Directors Shares Voted Director Nominee For Withheld Broker Non-Votes Joshua Riggs 83,530,246 867,017 43,376,020 Andrew Arno 83,418,588 978,675 43,376,020 Alfred D. Kingsley 78,869,742 5,527,521 43,376,020 Andrew J. Last 80,339,227 4,058,036 43,376,020 Louis E. Silverman 82,542,629 1,854,634 43,376,020
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642380/000149315223022912/0001493152-23-022912-index.htm
- Shareholder Votes
  Insight Molecular Diagnostics Inc. shareholders approved To ratify the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accountants for the fiscal year ending December 31, 2023. at the 2023-06-23 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-23
  source text: 2. Ratification of Independent Registered Public Accounting Firm Shares Voted For Against Abstained Broker Non-Votes 126,399,465 714,459 659,359 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642380/000149315223022912/0001493152-23-022912-index.htm
- Shareholder Votes
  Insight Molecular Diagnostics Inc. shareholders approved To approve, on an advisory basis, the Company’s named executive officer compensation in fiscal 2022. at the 2023-06-23 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-23
  source text: 3. Advisory Vote to Approve Named Executive Officer Compensation Shares Voted For Against Abstained Broker Non-Votes 78,956,918 5,312,531 127,814 43,376,020
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642380/000149315223022912/0001493152-23-022912-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.